K V Pharma CL A (KVA)

K V Pharma CL A

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:KVA

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
18/06/2012	14:04	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVA	K V Pharma CL A
18/06/2012	12:08	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVA	K V Pharma CL A
17/11/2011	01:15	Business Wire	Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
03/11/2011	01:40	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
01/11/2011	01:30	Business Wire	Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
28/10/2011	21:30	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
24/10/2011	18:52	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
21/10/2011	01:47	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
13/10/2011	14:02	Business Wire	Zeldes & Haeggquist, LLP Announces Investigation of K-V Pharmaceutical	NYSE:KVA	K V Pharma CL A
13/06/2011	13:00	PR Newswire (US)	K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call	NYSE:KVA	K V Pharma CL A
01/04/2011	20:08	Dow Jones News	UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry	NYSE:KVA	K V Pharma CL A
01/04/2011	15:28	Dow Jones News	K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move	NYSE:KVA	K V Pharma CL A
31/03/2011	22:28	Dow Jones News	Religious Groups Urge Drug Makers To Ease Up On Price Hikes	NYSE:KVA	K V Pharma CL A
30/03/2011	20:58	Dow Jones News	UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVA	K V Pharma CL A
30/03/2011	17:38	Dow Jones News	K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVA	K V Pharma CL A
01/03/2011	13:49	PR Newswire (US)	K-V Pharmaceutical Company Announces $200 Million Private Debt Offering	NYSE:KVA	K V Pharma CL A
14/02/2011	15:36	PR Newswire (US)	KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call Comments	NYSE:KVA	K V Pharma CL A
14/02/2011	15:34	PR Newswire (US)	K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue	NYSE:KVA	K V Pharma CL A
14/02/2011	14:48	PR Newswire (US)	K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock	NYSE:KVA	K V Pharma CL A
04/02/2011	13:40	PR Newswire (US)	K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011	NYSE:KVA	K V Pharma CL A
12/01/2011	14:03	PR Newswire (US)	K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™	NYSE:KVA	K V Pharma CL A
14/09/2010	15:29	Dow Jones News	K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval	NYSE:KVA	K V Pharma CL A
10/09/2010	14:53	Dow Jones News	K-V Pharma Soars On FDA Approval To Return Product To Market	NYSE:KVA	K V Pharma CL A
25/02/2010	18:53	PR Newswire (US)	KV Pharmaceutical Reaches Agreement with U.S. Department of Justice	NYSE:KVA	N^CURN
28/01/2010	22:04	Business Wire	Robbins Umeda LLP Announces Investigation of KV Pharmaceutical Company	NYSE:KVA	K V Pharma CL A
20/01/2010	20:41	Dow Jones News	UPDATE: Watson Pharma Benefits From Toprol Market Presence	NYSE:KVA	K V Pharma CL A
20/01/2010	19:11	Dow Jones News	Watson Pharma Continues To Benefit From Toprol Market Presence	NYSE:KVA	K V Pharma CL A
11/01/2010	14:18	PR Newswire (US)	KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)	NYSE:KVA
07/01/2010	21:10	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director	NYSE:KVA
22/12/2009	22:34	PR Newswire (US)	KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010	NYSE:KVA